close

WuXi PharmaTech (Cayman) Inc., through its subsidiaries, operates as a pharmaceutical, biotechnology, and medical device research and development outsourcing company in the People's Republic of China and the United States. The company provides laboratory services for pharmaceutical companies, which include discovery and medicinal chemistry, analytical chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation, and toxicology services, as well as drug metabolism and pharmacokinetics/absorption, distribution, metabolism, and excretion services. It also offers services in antibody generation, cell line development, and biologics safety testing that support customersÂ’ biologics product development and commercialization; and medical device testing and development services. In addition, the company provides manufacturing services for producing advanced intermediates and active pharmaceutical ingredients for use by pharmaceutical companies in preclinical and clinical trials. It offers its services directly to pharmaceutical, biotechnology, and medical device companies. The company was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	14.81
Volume	832127
Volume Avg	385443
52 Week High	19.10
52 Week Low	10.65
PE	13.79
PE (group average)	N/A
EPS Year	1.04
EPS change Q/Q	0%
EPS change Q/Q Yr ago	0%
EPS change Q/Q next Q est	-90%
EPS change Y/Y	-31.25%
REV change Q/Q	5.64%
REV change Q/Q Yr ago	16.13%
EPS next Q est	0.30
EPS next Y est	1.29
Divident Annual	0.00
Dividend Yield	0%